(Total Views: 579)
Posted On: 07/28/2022 12:48:37 PM
Post# of 145254
![Avatar](https://investorshangout.com/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
Pfizer abandons a NASH drug that, surprise surprise, doesn't work.
https://www.fiercebiotech.com/biotech/nash-cu...3792801H0W
https://www.fiercebiotech.com/biotech/nash-cu...3792801H0W
Quote:
It’s not the first NASH drug to be culled from Pfizer’s pipeline, either. The Big Pharma dropped the ketohexokinase inhibitor PF-06835919 after a mid-stage trial a year ago, and had previously halted PF-05221304 and a DGAT2 inhibitor for the liver condition.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)